Hospital
Walthall General Hospital
Walthall General Hospital was paid $6.16M by Medicaid between Jan 2018 and Nov 2024, across 81 billing codes. Its largest line is 99283, emergency room visit (moderate) — 29% of everything it billed.
33Billing provider infoWALTHALL GENERAL HOSPITAL
TYLERTOWN, MS 39667
TYLERTOWN, MS 39667
33aNPI1023326485assigned 09/20/2010
33bProvider typeCritical Access Hospital
28Total paid$6.16M
24GClaims146,726
24DCodes billed81
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in Mississippi
Rank by total paid#12 of 32
Median peer was paid$3.94M
This provider vs. median1.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official HESTER, BEN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 21,628 | $955K | |
| 2019 | 23,089 | $1.10M | |
| 2020 | 16,094 | $655K | |
| 2021 | 20,145 | $789K | |
| 2022 | 25,809 | $982K | |
| 2023 | 24,286 | $1.02M | |
| 2024incomplete | 15,675 | $658K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 29% | 12,625 | 10,889 | $1.76M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 5,677 | 4,996 | $1.11M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.3% | 2,254 | 1,982 | $509K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.5% | 2,679 | 2,346 | $274K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.9% | 1,325 | 1,202 | $242K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3.2% | 3,203 | 2,766 | $200K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.9% | 5,793 | 5,003 | $178K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.5% | 1,612 | 1,447 | $152K |
| 87634 | 2.3% | 3,198 | 2,763 | $144K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.3% | 1,651 | 1,501 | $143K |
| G0378 | Hospital observation service, per hour | 2.0% | 529 | 458 | $123K |
| 71046 | Radiologic examination, chest; 2 views | 2.0% | 2,708 | 2,367 | $121K |
69 more codes
| 71045 | Radiologic examination, chest; single view | 1.8% | 2,879 | $114K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.7% | 3,191 | $107K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.5% | 2,086 | $92K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.2% | 691 | $75K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.2% | 1,754 | $73K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.1% | 3,123 | $65K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 10,078 | $54K |
| 80053 | Comprehensive metabolic panel | <1% | 7,035 | $49K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,942 | $49K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,842 | $47K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,199 | $33K |
| 83880 | <1% | 1,421 | $30K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,326 | $29K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,145 | $26K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,799 | $23K |
| 87430 | <1% | 1,830 | $23K | |
| 81025 | <1% | 3,825 | $22K | |
| 74018 | <1% | 417 | $21K | |
| 84484 | <1% | 2,571 | $21K | |
| 82553 | <1% | 2,576 | $19K | |
| 36592 | <1% | 2,850 | $18K | |
| 73562 | <1% | 351 | $16K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,498 | $16K |
| 80061 | Lipid panel | <1% | 1,453 | $15K |
| 81001 | <1% | 6,597 | $15K | |
| A9270 | Non-covered item or service | <1% | 4,596 | $15K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 690 | $15K |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,873 | $15K |
| 72100 | <1% | 170 | $12K | |
| 87081 | <1% | 1,620 | $12K | |
| 82550 | <1% | 3,193 | $11K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,415 | $10K |
| 87186 | <1% | 1,252 | $9K | |
| 87077 | <1% | 1,282 | $9K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 61 | $9K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 35 | $5K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 57 | $5K |
| 83735 | <1% | 562 | $3K | |
| 73630 | <1% | 60 | $2K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 13 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 40 | $2K |
| 73030 | <1% | 28 | $2K | |
| 82962 | <1% | 497 | $1K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 22 | $1K |
| 73502 | <1% | 24 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,920 | $1K |
| 82150 | <1% | 286 | $997.31 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 52 | $891.31 |
| 73610 | <1% | 14 | $828.81 | |
| 83605 | <1% | 111 | $707.18 | |
| 80305 | <1% | 128 | $688.08 | |
| 85730 | <1% | 150 | $677.76 | |
| 97032 | <1% | 49 | $672.39 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 878 | $646.20 |
| 85610 | <1% | 205 | $627.57 | |
| 82607 | <1% | 42 | $565.77 | |
| 87070 | <1% | 53 | $488.75 | |
| 74019 | <1% | 28 | $396.56 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,993 | $330.32 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,970 | $259.18 |
| 87205 | <1% | 67 | $213.92 | |
| 87420 | <1% | 18 | $203.35 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 15 | $191.22 |
| 84550 | <1% | 44 | $113.61 | |
| 94760 | <1% | 106 | $20.37 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 0% | 158 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 117 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 68 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 31 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHESTER, BEN (CFO)
Parent organizationFORREST GENERAL HOSPITAL
| Provider | Location | Paid |
|---|---|---|
| Forrest County General Hospital | Hattiesburg, MS | $81.63M |
| Forrest County General Hospital | Picayune, MS | $21.66M |
| Forrest County General Hospital | Columbia, MS | $9.51M |
| Forrest County General Hospital | Prentiss, MS | $3.80M |
| Forrest County General Hospital | Poplarville, MS | $3.74M |
| Forrest County General Hospital | Poplarville, MS | $2.80M |
| Forrest County General Hospital | Picayune, MS | $2.76M |
| Forrest County General Hospital | Richton, MS | $1.58M |
| Forrest County General Hospital | Richton, MS | $1.36M |
| Forrest County General Hospital | Columbia, MS | $1.03M |
| Walthall General Hospital | Tylertown, MS | $953K |
| Forrest General Hospital | Hattiesburg, MS | $850K |
| Forrest County General Hospital | Poplarville, MS | $253K |
| FGH Physician Billing | Hattiesburg, MS | $224K |
| Forrest County General Hospital | Prentiss, MS | $204K |
| Forrest County General Hospital | Picayune, MS | $65K |
| FGH Trauma Surgery Clinic | Hattiesburg, MS | $47K |
| Forrest County General Hospital | Poplarville, MS | $22K |
| Forrest County General Hospital | Richton, MS | $18K |
| Walthall General Hospital | Tylertown, MS | $3K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.